Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tommaso Viva"'
Autor:
Tommaso Viva, Adriana Postolache, Mai-Linh Nguyen Trung, Pauline Danthine, Hélène Petitjean, Vito Domenico Bruno, Christophe Martinez, Mathieu Lempereur, Marco Guazzi, Samy Aghezzaf, Augustin Coisne, Cécile Oury, Raluca Dulgheru, Patrizio Lancellotti
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionAlthough staging of the extent of aortic stenosis (AS)-related cardiac damages is usually performed via echocardiography, this technique has considerable limitations in assessing pulmonary artery and right chamber pressures. The present h
Externí odkaz:
https://doaj.org/article/eb45766e7e294b4d99a126478216f8a2
Autor:
Guglielmo Gallone, Fabian Islas, Riccardo Gorla, Francesco Melillo, Pier Pasquale Leone, Paolo Cimaglia, Maria Concetta Pastore, Anna Franzone, Federico Landra, Francesco Bruno, Luca Scudeler, Pilar Jimenez-Quevedo, Tommaso Viva, Francesco Piroli, Renato Bragato, Michele Trichilo, Anna Degiovanni, Federica Ilardi, Alessandro Andreis, Luis Nombela-Franco, Tusa Maurizio, Marco Toselli, Federico Conrotto, Matteo Montorfano, Rachele Manzo, Matteo Cameli, Giuseppe Patti, Giulio Stefanini, Luca Testa, Francesco Giannini, Eustachio Agricola, Javier Escaned, Fabrizio D’Ascenzo, Gaetano M De Ferrari
Publikováno v:
European Heart Journal - Cardiovascular Imaging.
Aims The prognostic impact of flow trajectories according to stroke volume index (SVi) and transvalvular flow rate (FR) in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) remains poorly assessed. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18bac01409536dc424784f9438ca5224
https://doi.org/10.1093/ehjci/jead018
https://doi.org/10.1093/ehjci/jead018
Autor:
Armando Patrizio, Tommaso Viva, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Alessandro Antonelli, Poupak Fallahi
Publikováno v:
Autoimmunity Reviews. 22:103238
Since 1997, when the first case of autoimmune hyperthyroidism induced by Interferon (IFN)-β1b therapy was described, we know about the risk of thyroid dysfunction related to this treatment, particularly in patients with preexisting thyroid autoimmun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::846eb2985fc01e937198c218b633aa3e
https://doi.org/10.1016/j.autrev.2022.103238
https://doi.org/10.1016/j.autrev.2022.103238
Autor:
Massimiliano M. Marrocco-Trischitta, Valerio Mecarocci, Ewa Witkowska, Andrea Bernardini, Carlo Pappone, Francesca Santini, Serenella Castelvecchio, Roberto Rondine, Emanuela T. Locati, Gabriele Vicedomini, Carlo de Innocentiis, Lorenzo Menicanti, Giuseppe Ciconte, Gabriele Negro, Tommaso Viva, Luigi Giannelli
Publikováno v:
International Journal of Cardiology
Background Hydroxychloroquine (HCQ) and azithromycin (AZT) have been proposed for COVID-19 treatment. Data available in the literature reported a potential increased risk of fatal arrhythmias under these therapies. The aim of this study was to assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f436b154701792acee9e1b381ba2b081
https://pubmed.ncbi.nlm.nih.gov/32956782
https://pubmed.ncbi.nlm.nih.gov/32956782